R-CHOP is the treatment regimen used for the management of Non Hodgkin’s Lymphomas, which involves the inclusion of a drug ’Rituximab’ in addition to the conventional CHOP drug therapy ( which consists of three chemotherapy drugs and one steroid). R-CHOP has several scientifically proven advantages over the conventional chemotherapy used for the management of Non Hodgkin’s Lymphoma. Mexico, Turkey, Jordan, India, and Costa Rica are the preferred destinations to have the therapy conducted abroad.
In addition to the chemotherapy drugs used in the CHOP regimen (Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone), R-CHOP includes the addition of a ‘Rituximab’, which is a monoclonal antibiotic which attaches itself with proteins, called CD 20, located on the surface of B-cells. B cells are the cancerous cells which are found in most of the types of non Hodgkin’s lymphoma. Rituximab helps immune cells to identify the B cells, by attaching itself on the cell surface. Once identified, B cells are destroyed by our immune system.
Like CHOP, R-CHOP chemotherapy is also given in three to eight cycles. Based on the number of days each cycle lasts, the chemotherapy regimen is classified as R-CHOP 14 (for a 14 day cycle) or R-CHOP 21 (for a 21 day cycle). The drugs and their doses remain same in both the treatment options, only the break time between the treatments is altered.
It is essential to understand that some of the side effects may be annoying, causing inconvenience but they don’t damage the overall health in the long run. However some of the side effects are serious medical conditions and inevitably require the intervention of the medical team. It is thus essential to discuss all the side effects with your medical team.
Some considerations before initiating RCHOP regimen for Non Hodgkin’s Lymphoma:
R-CHOP chemotherapy regimen has several proven advantages over the standard CHOP regimen. It increases chances of survival and is effective for several more diffused and aggressive forms of Non Hodgkin’s Lymphomas. The chemotherapy also allows shorter cycles. However the extent of the complications and side effects remain same and depend largely on individual sensitivity to the drugs, age and other personal considerations.
India provides the most appropriate, apt, and high levels of medical care and management of non Hodgkin’s lymphoma through the R-CHOP regimen. The procedures are priced at low figures. Notably, lower costs do not signify that the levels of standard and quality are compromised. India grants top quality health care speedily and inexpensively.
Turkey offers the R-CHOP treatment at a portion of the cost that is charged in the United States, while not making any kind of concessions with the level of excellence and quality. Adroit medical personnel and health care faculty, and the speedy management of cancer patients has put Turkey in the spot light.
Jordan provides better improved and highly developed cancer management facilities, including modern and advanced methods and equipments. Cheap, cost effective, speedy, and ideal care is the hallmark of the country, when it comes to providing medical assistance.
The country has specifically focused on the treatment and management of various kinds of cancers. This has given it a further boost over other countries in treatment of malignancies and cancers. It grants the R-CHOP regimen at affordable rates.
Costa Rica provides the most appropriate and advanced levels of medical care and treatment for cancer patients. It offers international levels of optimum health care quickly and cheaply.
Cyberknife in India
Cyberknife at Anadolu Medical Center, Turkey
Chemotherapy Treatment (CHOP) Abroad
Cyberknife Cancer Radiotherapy Overseas
Medical Tourism Corporation facilitates affordable R-CHOP Chemotherapy in Europe (Turkey) and other overseas world-class oncology treatment destinations.
*Please review our full disclaimers, Terms & Conditions and, Health Privacy & Confidentiality Statement. Individual results may vary. The statements on this website have not been evaluated by the FDA or any medical professional.